Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interception of Minimal Residual Disease in Solid Malignancies
NCT07268469Not yet recruiting
- Sponsor
- European Institute of Oncology
- Start
- Dec 2025
- Primary completion
- Jul 2033
01
Overview
Single-arm trial, sponsored by European Institute of Oncology. Primary endpoints: ctDNA detection after surgery at 28 days and ctDNA detection at 6 months after the start of adjuvant therapy. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07268469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07268469.